These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16543089)

  • 1. Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients.
    Cha S
    Neuroimaging Clin N Am; 2006 Feb; 16(1):137-47, ix. PubMed ID: 16543089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion MR imaging: basic principles and clinical applications.
    Cha S
    Magn Reson Imaging Clin N Am; 2003 Aug; 11(3):403-13. PubMed ID: 14768726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R; Babb J; Law M; Pollack E; Johnson G
    J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
    Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
    Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
    Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
    Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
    Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
    J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
    Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
    Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study.
    Chaskis C; Stadnik T; Michotte A; Van Rompaey K; D'Haens J
    Acta Neurochir (Wien); 2006 Mar; 148(3):277-85; discussion 285. PubMed ID: 16421765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance perfusion and permeability imaging in brain tumors.
    Lacerda S; Law M
    Neuroimaging Clin N Am; 2009 Nov; 19(4):527-57. PubMed ID: 19959004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner.
    Ulmer S; Reeh M; Krause J; Herdegen T; Heldt-Feindt J; Jansen O; Rohr A
    J Neurosci Methods; 2008 Jul; 172(2):168-72. PubMed ID: 18538856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR perfusion-weighted imaging may help in differentiating between nonenhancing gliomas and nonneoplastic lesions in the cervicomedullary junction.
    Liu X; Kolar B; Tian W; Germin BI; Huang Y; Hu R; Zhong J; Ekholm S
    J Magn Reson Imaging; 2011 Jul; 34(1):196-202. PubMed ID: 21618332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach.
    Wirestam R; Knutsson L; Risberg J; Börjesson S; Larsson EM; Gustafson L; Passant U; Ståhlberg F
    Acta Radiol; 2007 Jun; 48(5):550-6. PubMed ID: 17520432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.
    Cha S; Knopp EA; Johnson G; Wetzel SG; Litt AW; Zagzag D
    Radiology; 2002 Apr; 223(1):11-29. PubMed ID: 11930044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
    Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
    J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
    Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
    NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
    Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
    J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging.
    Batra A; Tripathi RP; Singh AK
    Australas Radiol; 2004 Sep; 48(3):324-32. PubMed ID: 15344981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.